Müller F
Immun Infekt. 1982 Jan;10(1):23-34.
This study is based on the results of investigations with the 19S(IgM)-FTA-ABS in serum samples of more than 10,000 patients with treated or untreated syphilis. On the basis of the findings several experiences concerning the technique of the test as well as the possibilities of biological or technical errors are reported. Furthermore, the interpretation of test results is discussed. It is shown that in many cases a differentiation between sufficiently treated and those patients is possible who need specific treatment. Finally the indications for preparing the test are mentioned. It is concluded that at the present time the performance of the 19S(IgM)-FTA-ABS test should be restricted to specialized laboratories.
本研究基于对10000多名已治疗或未治疗梅毒患者血清样本进行19S(IgM)-FTA-ABS检测的结果。根据这些发现,报告了有关该检测技术以及生物学或技术误差可能性的一些经验。此外,还讨论了检测结果的解读。结果表明,在许多情况下,可以区分治疗充分的患者和需要特殊治疗的患者。最后提到了进行该检测的指征。得出的结论是,目前19S(IgM)-FTA-ABS检测应限于专业实验室进行。